Shelton Capital Management Myriad Genetics Inc Transaction History

Shelton Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$22.08 - $47.08 $161,184 - $343,684	-7,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $159,800 - $246,715	7,049 Added 2808.37%	7,300 $203,000
Q1 2019 May 10, 2019	SELL	$26.93 - $34.7 $197,073 - $253,934	-7,318 Reduced 96.68%	251 $7.57 Million
Q4 2018 Jan 31, 2019	BUY	$27.23 - $45.56 $15,112 - $25,285	555 Added 7.91%	7,569 $220,000
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $16,455 - $22,048	438 Added 6.66%	7,014 $323,000
Q2 2018 Aug 10, 2018	BUY	$27.75 - $40.17 $182,484 - $264,157	6,576 New	6,576 $246,000
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $189,586 - $269,681	-6,576 Closed	0 $0
Q3 2017 Nov 28, 2017	BUY	$24.01 - $36.2 $157,889 - $238,051	6,576	6,576 $238,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.